An elusive debate on the evidence for RNA editing in SARS-CoV-2

References

• Pu X, Xu Q, Wang J, et al. The continuing discovery on the evidence for RNA editing in SARS-CoV-2. RNA Biol. 2023;20(1):219–222. doi: 10.1080/15476286.2023.2214437
   PubMed Web of Science ®Google Scholar
• Di Giorgio S, Martignano F, Torcia MG, et al. Evidence for host-dependent RNA editing in the transcriptome of SARS-CoV-2. Sci Adv. 2020;6(25). doi: 10.1126/sciadv.abb5813
   PubMed Web of Science ®Google Scholar
• Graudenzi A, Maspero D, Angaroni F, et al. Mutational signatures and heterogeneous host response revealed via large-scale characterization of SARS-CoV-2 genomic diversity. iScience. 2021;24(2):102116. doi: 10.1016/j.isci.2021.102116
   PubMed Web of Science ®Google Scholar
• Gregori J, Cortese MF, Piñana M, et al. Host-dependent editing of SARS-CoV-2 in COVID-19 patients. Emerg Microbes Infect. 2021;10(1):1777–1789. doi: 10.1080/22221751.2021.1969868
   PubMed Web of Science ®Google Scholar
• Lythgoe KA, Hall M, Ferretti L, et al. SARS-CoV-2 within-host diversity and transmission. Science. 2021;372(6539). doi: 10.1126/science.abg0821
   PubMed Web of Science ®Google Scholar
• Pathak AK, Mishra GP, Uppili B, et al. Spatio-temporal dynamics of intra-host variability in SARS-CoV-2 genomes. Nucleic Acids Res. 2022;50(3):1551–1561. doi: 10.1093/nar/gkab1297
   PubMed Web of Science ®Google Scholar
• Picardi E, Mansi L, Pesole G. Detection of A-to-I RNA editing in SARS-COV-2. Genes. 2021;13(1):41 doi: 10.3390/genes13010041
   PubMed Web of Science ®Google Scholar
• Popa A, Genger J-W, Nicholson MD, et al. Genomic epidemiology of superspreading events in Austria reveals mutational dynamics and transmission properties of SARS-CoV-2. Sci Transl Med. 2020;12(573). doi: 10.1126/scitranslmed.abe2555
   PubMed Web of Science ®Google Scholar
• Song Y, He X, Yang W, et al. Virus-specific editing identification approach reveals the landscape of A-to-I editing and its impacts on SARS-CoV-2 characteristics and evolution. Nucleic Acids Res. 2022;50(5):2509–2521. doi: 10.1093/nar/gkac120
   PubMed Web of Science ®Google Scholar
• Tonkin-Hill G, Martincorena I, Amato R, et al. Patterns of within-host genetic diversity in SARS-CoV-2. Elife. 2021. doi: 10.7554/eLife.66857
   Web of Science ®Google Scholar
• Voloch CM, da Silva FR Jr, De Almeida LGP, et al. Intra-host evolution during SARS-CoV-2 prolonged infection. Virus Evol. 2021;7(2). doi: 10.1093/ve/veab078
   Web of Science ®Google Scholar
• Wang Y, Wang D, Zhang L, et al. Intra-host variation and evolutionary dynamics of SARS-CoV-2 populations in COVID-19 patients. Genome Med. 2021;13(1):
   Web of Science ®Google Scholar
• Azgari C, Kilinc Z, Turhan B, et al. The mutation profile of SARS-CoV-2 is primarily shaped by the Host antiviral defense. Viruses. 2021;10(3):394.
   Google Scholar
• Deng S, Xing K, He X Mutation signatures inform the natural host of SARS-CoV-2. bioRxiv 2021. doi: 10.1101/2021.07.05.451089
   Google Scholar
• Friedman N, Jacob-Hirsch J, Drori Y, et al. Transcriptomic profiling and genomic mutational analysis of human coronavirus (HCoV)-229E -infected human cells. PloS One. 2021;16(2):e0247128. doi: 10.1371/journal.pone.0247128
   PubMed Web of Science ®Google Scholar
• Klimczak LJ, Randall TA, Saini N, et al. Similarity between mutation spectra in hypermutated genomes of rubella virus and in SARS-CoV-2 genomes accumulated during the COVID-19 pandemic. PloS One. 2020;15(10):e0237689. doi: 10.1371/journal.pone.0237689
   PubMed Web of Science ®Google Scholar
• Kosuge M, Furusawa-Nishii E, Ito K, et al. Point mutation bias in SARS-CoV-2 variants results in increased ability to stimulate inflammatory responses. Sci Rep. 2020;10(1):17766. doi: 10.1038/s41598-020-74843-x
   PubMed Web of Science ®Google Scholar
• Matyášek R, Řehůřková K, Berta Marošiová K, et al. Mutational asymmetries in the SARS-CoV-2 genome May Lead to increased hydrophobicity of virus proteins. Genes. 2021;10(6):826. doi: 10.3390/genes12060826
   Google Scholar
• Pang X, Li P, Zhang L, et al. Emerging severe acute respiratory syndrome coronavirus 2 mutation hotspots associated with clinical outcomes and transmission. Front Microbiol. 2021. doi: 10.3389/fmicb.2021.753823.
   Google Scholar
• Rice AM, Castillo Morales A, Ho AT, et al. Evidence for Strong Mutation Bias toward, and selection against, U content in SARS-CoV-2: implications for vaccine design. Mol Biol Evol. 2021. doi: 10.1093/molbev/msaa188
   Web of Science ®Google Scholar
• Sadykov M, Mourier T, Guan Q, et al. Short sequence motif dynamics in the SARS-CoV-2 genome suggest a role for cytosine deamination in CpG reduction. J Mol Cell Biol. 2021;13(3):225–227. doi: 10.1093/jmcb/mjab011
   PubMed Web of Science ®Google Scholar
• Simmonds P, Schwemmle M. Rampant C→U hypermutation in the genomes of SARS-CoV-2 and other coronaviruses: causes and consequences for their short- and long-term evolutionary trajectories. mSphere. 2020;5(3). doi: 10.1128/mSphere.00408-20
   PubMed Web of Science ®Google Scholar
• Simmonds P, Ansari MA, Pichlmair A. Extensive C->U transition biases in the genomes of a wide range of mammalian RNA viruses; potential associations with transcriptional mutations, damage- or host-mediated editing of viral RNA. PloS Pathog. 2021;17(6):e1009596. doi: 10.1371/journal.ppat.1009596
   PubMed Web of Science ®Google Scholar
• Tasakis RN, Samaras G, Jamison A, et al. SARS-CoV-2 variant evolution in the United States: high accumulation of viral mutations over time likely through serial Founder events and mutational bursts. PloS One. 2021;16(7):e0255169. doi: 10.1371/journal.pone.0255169
   PubMed Web of Science ®Google Scholar
• Van Dorp L, Richard D, Tan CCS, et al. No evidence for increased transmissibility from recurrent mutations in SARS-CoV-2. Nat Commun. 2020;11(1):5986. doi: 10.1038/s41467-020-19818-2
   PubMed Web of Science ®Google Scholar
• Cai H, Liu X, Zheng X. RNA editing detection in SARS-CoV-2 transcriptome should be different from traditional SNV identification. J Appl Genet. 2022;63(3):587–594. doi: 10.1007/s13353-022-00706-y
   PubMed Web of Science ®Google Scholar
• Song Y, He X, Yang W, et al. Virus-specific editing identification approach reveals the landscape of A-to-I editing and its impacts on SARS-CoV-2 characteristics and evolution. Nucleic Acids Res. 2022;50(5):2509–2521. doi: 10.1093/nar/gkac120
   PubMed Web of Science ®Google Scholar
• Smith EC, Blanc H, Vignuzzi M, et al. Coronaviruses lacking exoribonuclease activity are susceptible to lethal mutagenesis: evidence for proofreading and potential therapeutics. PloS Pathog. 2013;9(8):e1003565. doi: 10.1371/journal.ppat.1003565
   PubMed Web of Science ®Google Scholar
• Yin X, Popa H, Stapon A, et al. Fidelity of ribonucleotide incorporation by the SARS-CoV-2 replication complex. J Mol Biol. 2023;435(5):167973. doi: 10.1016/j.jmb.2023.167973
   PubMed Web of Science ®Google Scholar
• Martignano F, Di Giorgio S, Mattiuz G, et al. Commentary on “poor evidence for host-dependent regular RNA editing in the transcriptome of SARS-CoV-2”. J Appl Genet. 2022;63(2).
   PubMed Web of Science ®Google Scholar
• Kim K, Calabrese P, Wang S, et al. The roles of APOBEC-mediated RNA editing in SARS-CoV-2 mutations, replication and fitness. Sci Rep. 2022;12(1):14972. doi: 10.1038/s41598-022-19067-x
   PubMed Web of Science ®Google Scholar
• Nakata Y, Ode H, Kubota M, et al. Cellular APOBEC3A deaminase drives mutations in the SARS-CoV-2 genome. Nucleic Acids Res. 2023;51(2):783–795. doi: 10.1093/nar/gkac1238
   PubMed Web of Science ®Google Scholar